Research ArticleArticle
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment
Annelieke Pasma, Adriaan van’t Spijker, Jolanda J. Luime, Margot J.M. Walter, Jan J.V. Busschbach and Johanna M.W. Hazes
The Journal of Rheumatology December 2014, jrheum.140693; DOI: https://doi.org/10.3899/jrheum.140693
Annelieke Pasma
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Supported by Reumafonds (grant number 10-1-413). A. Pasma, MSc; J.J. Luime, PhD; M.J.M. Walter, MSc; J.M.W. Hazes, MD, PhD, Department of Rheumatology; A. van ’t Spijker, PhD; J.J.V. Busschbach, PhD, Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam. Address correspondence to Dr. A. Pasma, Department of Rheumatology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. E-mail: a.pasma@erasmusmc.nl Accepted for publication October 21, 2014.
Adriaan van’t Spijker
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Supported by Reumafonds (grant number 10-1-413). A. Pasma, MSc; J.J. Luime, PhD; M.J.M. Walter, MSc; J.M.W. Hazes, MD, PhD, Department of Rheumatology; A. van ’t Spijker, PhD; J.J.V. Busschbach, PhD, Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam. Address correspondence to Dr. A. Pasma, Department of Rheumatology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. E-mail: a.pasma@erasmusmc.nl Accepted for publication October 21, 2014.
Jolanda J. Luime
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Supported by Reumafonds (grant number 10-1-413). A. Pasma, MSc; J.J. Luime, PhD; M.J.M. Walter, MSc; J.M.W. Hazes, MD, PhD, Department of Rheumatology; A. van ’t Spijker, PhD; J.J.V. Busschbach, PhD, Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam. Address correspondence to Dr. A. Pasma, Department of Rheumatology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. E-mail: a.pasma@erasmusmc.nl Accepted for publication October 21, 2014.
Margot J.M. Walter
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Supported by Reumafonds (grant number 10-1-413). A. Pasma, MSc; J.J. Luime, PhD; M.J.M. Walter, MSc; J.M.W. Hazes, MD, PhD, Department of Rheumatology; A. van ’t Spijker, PhD; J.J.V. Busschbach, PhD, Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam. Address correspondence to Dr. A. Pasma, Department of Rheumatology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. E-mail: a.pasma@erasmusmc.nl Accepted for publication October 21, 2014.
Jan J.V. Busschbach
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Supported by Reumafonds (grant number 10-1-413). A. Pasma, MSc; J.J. Luime, PhD; M.J.M. Walter, MSc; J.M.W. Hazes, MD, PhD, Department of Rheumatology; A. van ’t Spijker, PhD; J.J.V. Busschbach, PhD, Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam. Address correspondence to Dr. A. Pasma, Department of Rheumatology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. E-mail: a.pasma@erasmusmc.nl Accepted for publication October 21, 2014.
Johanna M.W. Hazes
From Department of Rheumatology, Department of Psychiatry, and Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Supported by Reumafonds (grant number 10-1-413). A. Pasma, MSc; J.J. Luime, PhD; M.J.M. Walter, MSc; J.M.W. Hazes, MD, PhD, Department of Rheumatology; A. van ’t Spijker, PhD; J.J.V. Busschbach, PhD, Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus Medical Center, University Medical Center Rotterdam. Address correspondence to Dr. A. Pasma, Department of Rheumatology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. E-mail: a.pasma@erasmusmc.nl Accepted for publication October 21, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment
Annelieke Pasma, Adriaan van’t Spijker, Jolanda J. Luime, Margot J.M. Walter, Jan J.V. Busschbach, Johanna M.W. Hazes
The Journal of Rheumatology Dec 2014, jrheum.140693; DOI: 10.3899/jrheum.140693
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment
Annelieke Pasma, Adriaan van’t Spijker, Jolanda J. Luime, Margot J.M. Walter, Jan J.V. Busschbach, Johanna M.W. Hazes
The Journal of Rheumatology Dec 2014, jrheum.140693; DOI: 10.3899/jrheum.140693